⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28366036 | 0.79 | NAAA (0.39) | — | |
| SCHEMBL8916412 | 0.77 | ADRA2A (0.35) | — | |
| SCHEMBL609896 | 0.77 | ALDH1A1 (0.35) | — | |
| SCHEMBL28370362 | 0.76 | ALDH1A1 (0.50) | — | |
| SCHEMBL4462036 | 0.76 | LMNA (0.39) | — | |
| SCHEMBL609897 | 0.75 | ALDH1A1 (0.32) | — | |
| SCHEMBL27793873 | 0.74 | ADRA2A (0.38) | — | |
| SCHEMBL7818001 | 0.74 | DGKA (0.39) | — | |
| SCHEMBL27663709 | 0.74 | CHRM5 (0.38) | — | |
| SCHEMBL8032561 | 0.74 | CYP19A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669353-B1 | ANTIOXIDANT, ANTIOXIDANT COMPOSITION AND PRODUCTION METHOD THEREFOR | WATANABE OYSTER LABORATORY CO LTD (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-9012513-B2 | Antioxidant, antioxidant composition and production method therefor | WATANABE OYSTER LABORATORY CO., LTD. (JP) | 2015-04-21 | — | — | US | disclosed |
| EP-2669353-A1 | ANTIOXIDANT, ANTIOXIDANT COMPOSITION AND PRODUCTION METHOD THEREFOR | Watanabe Oyster Laboratory Co., Ltd. (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20130303629-A1 | ANTIOXIDANT, ANTIOXIDANT COMPOSTION AND PRODUCTION METHOD THEREFOR | WATANABE OYSTER LABORATORY CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| EP-0560147-B1 | 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same | MEIJI SEIKA KAISHA (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0852231-A2 | 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same | MEIJI SEIKA KAISHA LTD. (JP) | 1998-07-08 | — | — | EP | disclosed |
| US-5444174-A | Effective on grampositive bacteria | MEIJI SEIKA KAISHA, LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0560147-A1 | 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesic intermediate thereof and process for producing the same | MEIJI SEIKA KAISHA LTD. (JP) | 1993-09-15 | — | — | EP | disclosed |